* Vaccinex Inc VCNX.OQ reported a quarterly adjusted loss
of 21 cents per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 29 cents per
share.
* Reported revenue was zero.
* Vaccinex Inc's reported EPS for the quarter was a loss of 21
cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Vaccinex Inc shares had fallen by 16.1% this quarter and
gained 13.5% so far this year.
* The company reported a quarterly loss of $5.97 million.
* Wall Street's median 12-month price target for Vaccinex Inc is
$7.00
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated August 16 at 01:30 p.m. All
figures in US dollars unless otherwise stated